TSLP and pancreatic neoplasm: Protti and collaborators first demonstrated that human pancreatic cancer [pancreatic ductal adenocarcinoma (PDAC)]-derived TNF-α and IL-1 induced the release of TSLP from cancer-associated fibroblasts (CAFs) (146).